LISATA THERAPEUTICS, INC. — Director's Dealing 2016

Aug 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2016-08-05

Reporting Person: LOSORDO DOUGLAS W (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-05	Common Stock	A	1000	—	Acquired	15399	Direct

Footnotes

F1: These shares of common stock represent bonus shares that were granted to the Reporting Person pursuant to his employment agreement with the Issuer, dated as of July 23, 2013.

F2: Includes 4,748 shares of unvested restricted stock.